Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Moleculin Biotech (MBRX) Return on Assets (2016 - 2025)

Moleculin Biotech's Return on Assets history spans 10 years, with the latest figure at 1.18% for Q4 2025.

  • Quarterly results put Return on Assets at 1.18% for Q4 2025, up 12.0% from a year ago — trailing twelve months through Dec 2025 was 1.18% (up 12.0% YoY), and the annual figure for FY2025 was 1.28%, down 33.0%.
  • Return on Assets for Q4 2025 was 1.18% at Moleculin Biotech, down from 1.15% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.18% in Q2 2021 to a low of 2.47% in Q3 2024.
  • The 5-year median for Return on Assets is 1.14% (2023), against an average of 1.06%.
  • The sharpest move saw Return on Assets crashed -126bps in 2024, then skyrocketed 132bps in 2025.
  • Year by year, Return on Assets stood at 0.48% in 2021, then tumbled by -89bps to 0.91% in 2022, then crashed by -71bps to 1.56% in 2023, then grew by 17bps to 1.29% in 2024, then increased by 9bps to 1.18% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 1.18%, 1.15%, and 1.18% for Q4 2025, Q3 2025, and Q2 2025 respectively.